Research and Development
What if Europe became a leader in biotech innovation?
Unleashing Europe’s biotech prowess requires radical reinvention
Das Prinzip Jette Nietzard
Big Pharma is using tariffs to hold Europe to ransom
Von der Leyen, Macron knock Trump’s war on universities as ‘gigantic miscalculation’
French researchers to Macron: Take care of us before wooing Americans
Europe to burned American scientists: We’ll take you in
Sustainable edge
Europe looks to poach US researchers as Trump cuts funding
Twelve EU capitals want programs to bring over American scholars.
Italy, Spain back France’s plan to rescue EU chemicals industry
A ‘critical chemicals act’ would keep production of key molecules on EU soil, countries argue.
Development banks as key players in defense financing
Bank Gospodarstwa Krajowego and other national promotional bank institutions’ experience is readily available to leverage military expenditure in Europe.
Why connectivity matters to Europe’s tech sovereignty
From AI to edge cloud, the EU must become stronger in the global telecom value-chain
Merz won the German election. Here’s what it means for Europe.
POLITICO breaks down what the conservatives’ victory means for EU policy and cooperation ― from nuclear weapons to cannabis.
EU’s red tape bonfire stokes tech patent rows
A move by the European Commission to kill its standard essential patent rules has alarmed companies that license connectivity technology.
The menace of deindustrialization in the EU — and what we can do about it
Policymaking is not accountancy: in the medium and long term, the EU will be better off keeping factories within its borders.
Biotechs ‘cry for help’ to fix antibiotics market failure
Developers are reluctantly shelving promising drugs due to market failure.
Dutch pioneer files EU’s second lab-grown meat application
Mosa Meat says its cell-based beef is already affordable for restaurants.
Patient-centered innovation: Can Europe lead the way?
We can’t make true progress on unmet medical needs unless we understand what the patients themselves think they need or say is missing from their treatment options.
Arctic peace is crumbling, says top Faroe Islands politician
U.S. President-elect Donald Trump’s Greenland fixation has put the polar region firmly in the spotlight.
Europe’s economic apocalypse is now
Stagnation, flagging competitiveness, Donald Trump — the continent is facing “an existential challenge.”
Resetting Europe’s Innovation Compass
Europe’s pharmaceutical sector has grown slowly for 25 years and its share of research is shrinking. It’s time to turn things around
Cancer healthcare system readiness: Getting EU regulation and R&D on the same path
Pragmatism is key in evolving clinical trials for the betterment of patients
How do we close Europe’s innovation gap? Start with advanced connectivity and a strong intellectual property rights framework
Mobile technology underpins technologies ranging from AI to self-driving cars. To create more of these advances, we need proper incentives to further develop a dynamic standardization ecosystem that nurtures innovation.
Who’s going to pay for moving drug production to Europe?
Bringing drug production closer to home means reckoning with costs.
Overcoming the barriers to Europe’s leadership in medical innovation
Over the years, Europe’s share of global medicine R&D investments has dropped. However, with the new EU mandate, there is a chance to turn this around
Paris threatens millions in penalties if paracetamol-maker leaves France after US takeover
The deal has faced intense, cross-party scrutiny in Paris.
UK fudge on Horizon Brexit deal risks killing new research
Researchers celebrated a big post-Brexit deal to rejoin Horizon. Now they fear they will end up footing the bill.
Can Ozempic help drug addicts, too? A mega new study suggests it might.
Analysis of patient records suggests there could be some benefits, but more research is needed.
Boost EU research spending to €220B or lose against US, China, experts warn
A new report cites areas where the EU is lagging behind its rivals, and recommends a spending boost.
Rewriting Alzheimer’s future together – a call to action for G7 countries
Treatments for this disease have already advanced dramatically, but there is much further to go. We must take this historic opportunity to usher in a new era
Nonprofits lead the way on Marburg vaccines
Private sector has little enthusiasm for developing treatments for neglected tropical diseases.